Abstract:Poster session 3, September 23, 2022, 12:30 PM - 1:30 PMObjective: To determine the profile of fluconazole-resistant Candida isolates (FRCS) and the proportion of erg11 gene mutation in fluconazole-resistant C. albicans (FRCA) isolatesMethodsAfter getting approval from ethics the study was conducted on 150 isolates of FRCS obtained from patients admitted to our tertiary care hospital from September 2019 to December 2021. All the isolates were revived onto Sabouraud dextrose agar (SDA) and identified by Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS). Fluconazole-resistance was detected by VITEK 2 automated system. Deoxyribonucleic acid (DNA) of FRCA isolates were extracted by QIAamp DNA Mini kit (Qiagen-51 304, Hilden, Germany) as per manufacturer's instruction. A single primer pair targeting the nucleotide sequence from 1067 to 1576 bp region of erg11 gene was used for amplification as per Xu et al. with minor modification and 500 bp polymerase chain reaction (PCR) products were observed by gel electrophoresis. A positive clinical isolate of FRCA was used as a positive control. The PCR products were purified and subjected to Sanger sequencing with an ABI PRISM DNA analyzer (Applied Biosystems) and mutations were detected by using Mega (version 7) software by comparing with the published GenBank sequence AF153844.1 of C. albicans strain ATCC 28516. Categorical variables were expressed in percentages and continuous variables were expressed in mean (average).ResultsOut of the total of 150 FRCS, the most common fluconazole-resistant agent of candidiasis was C. auris , which was isolated from 60 (40%) cases followed by 24 (16%) isolates of C. glabrata , 19 (12.7%) isolates of C. krusei , 18 (12%) isolates of C. parapsilosis , 17 (11.3%) isolates of C. albicans , 10 (6.7%) isolates of C. tropicalis , and only two (1.3%) isolates of C. guilliermondii . Among these 17 FRCA isolates, 9 isolates were obtained from genital swabs, 5 from blood, and a single isolate each from the perianal swab, ear swab, and sputum. A total of 12 (70.6%) out of 17 FRCA isolates yielded 500 bp region in erg11 gene. Gel electrophoresis image of PCR products of erg11 gene is depicted in Figure 1. Sequencing of these products detected a single missense mutation A1309G (V437I) in one FRCA isolate. Most of the FRCA isolates had an average of 4 silent mutations (observed in 6 isolates) and a single isolate had 6 silent mutations. A total of 8 different silent mutations were observed among FRCA isolates T1296C (83.3%), C1203T (66.7%), A1440G (66.7%), C1302T (50%), T1470C (50%), T1140C (25%), T1110C (16.7%), and T1284C (8.3%).Conclusion C. auris was the most common fluconazole resistant isolate observed, followed by C. glabrata, C. krusei, C. parapsilosis, C. albicans, C. tropicalis , and C. guilliermondii . There were many silent mutations observed in erg11 gene of FRCA isolates and detected only a single missense mutation (V437I). Fluconazole-resistant in FRCA isolates may be due to mechanisms other than the studied one in our region.

Research on ERG11 Gene Mutations in Candida Albicans Resistance to Fluconazole

Comparative Study on the Partial ERG11 Gene Sequence Between the Yeast and Hyphal Forms of Candida Albicans

Correlation Between Antifungal Susceptibility of Clinical Isolates of Candida Albicans to Fluconazole and ERG11 Mutations

The relationship between ERG11 gene mutation of Candida albicans and fluconazole-resistance

In vitro fluconazole susceptibility of 1,903 clinical isolates of Candida albicans and the identification of ERG11 mutations.

Susceptibility Of Clinical Isolates Of Candida Species To Fluconazole And Detection Of Candida Albicans Erg11 Mutations

Analysis of ERG11 gene mutations in fluconazole-resistant Candida glabrata strains

Relationship Between Antifungal Resistance of Fluconazole Resistant Candida Albicans and Mutations in Erg11 Gene

ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates

Erg11 Mutations Associated with Azole Resistance in Clinical Isolates of Candida Albicans.

ERG11 Mutations Associated with Azole Resistance in Candida Albicans Isolates from Vulvovaginal Candidosis Patients

Erg 11 mutations associated with azole resistance in clinical isolates of Candida albicans Running title : Erg 11 mutations in Candida albicans

The A395T Mutation in ERG11 Gene Confers Fluconazole Resistance in Candida tropicalis Causing Candidemia

The Point Mutation of Cytochrome P-450 Lanosterol 14-Α Demethylase ERG11 Gene in Fluconazole-resistant Candida Albicans

Gene Expression Analysis of Key Players Associated with Fluconazole Resistance in Candida Albicans

Association of T916c (y257h) Mutation in Candida Albicans Erg11 with Fluconazole Resistance

P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates

Investigating role of positively selected genes and mutation sites of ERG11 in drug resistance of Candida albicans

[Molecular Mechanisms of Fluconazole Resistance in Clinical Isolates of Candida Glabrata].

Mechanism of fluconazole resistance of Candida tropicalis in clinical isolates

Correlation Between Azole Susceptibilities, Genotypes, and ERG11 Mutations in Candida Albicans Isolates Associated with Vulvovaginal Candidiasis in China